MEDI-543

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMEDI-543
Drug Alias NameListeria monocytogenes-based immunotherapy (Cerus/MedImmune)MEDI-EphA2live-attenuated Listeria monocytogenes -based vaccine (Cerus/MedImmune)Listeria monocytogenes-based immunotherapy (Cerus)L/A Lm-MCMV vaccine (Cerus/MedImmune) +[6] 
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionEphrin type-A receptor 2 modulators
TargetsEphrin type-A receptor 2
Therapy Area/IndicationsNeoplasmsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCerus Corp Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerus Corp IncMedimmune Llc
Active IndicationsN/A
Inactive IndicationsNeoplasmsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A